comparemela.com

Latest Breaking News On - Inspirmed inc - Page 1 : comparemela.com

InspirMed Highlights Encouraging Data on ISPM21 and ISPM19

InspirMed to Present at the 23rd International Society for Aerosols in Medicine (ISAM) Congress

Press release content from Globe Newswire. The AP news staff was not involved in its creation. InspirMed to Present at the 23rd International Society for Aerosols in Medicine (ISAM) Congress TLCApril 26, 2021 GMT SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, April 26, 2021 (GLOBE NEWSWIRE) InspirMed Inc., a subsidiary of TLC (Nasdaq: TLC, TWO: 4152) that specializes in the development of inhalable liposome formulation programs, announced today that a late-breaking abstract describing the potential advantages of ISPM21 and ISPM19 has been accepted by the scientific committee for poster presentation at the 23rd International Society for Aerosols in Medicine (ISAM) Congress. The poster, titled “A Strategy to Treat COVID-19 with Targeted Delivery of Inhalable Liposomal Antiviral Drugs”, has a poster number of 072 (New Devices and Emerging Therapies) and will be posted both on the website ( www.isam.org ) with an opportunity for a short oral presentation and printed for displ

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.